Analgesic effects of intravenous lidocaine and morphine on postamputation pain: A randomized double-blind, active placebo-controlled, crossover trial

Anesthesiology

Volumn 96, Issue 4, 2002, Pages 841-848

  Wu, Christopher L ^a   Tella, Prabhav ^a   Staats, Peter S ^a   Vaslav, Rachel ^a   Kazim, Debra A ^a   Wesselmann, Ursula ^a   Raja, Srinivasa N ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; LIDOCAINE; MORPHINE;

ADULT; AMPUTATION STUMP; ANALGESIA; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFUSION; LIMB AMPUTATION; MALE; NEUROMA; NEUROPATHY; PAIN ASSESSMENT; PATIENT SATISFACTION; PHANTOM PAIN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SOMATOSENSORY CORTEX;

ADULT; AGED; AMPUTATION; AMPUTATION STUMPS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LIDOCAINE; MALE; MIDDLE AGED; MORPHINE; PAIN, POSTOPERATIVE; PHANTOM LIMB;

EID: 0036201689     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200204000-00010     Document Type: Article

References (46)

1. Phantom sensation, phantom pain, and stump pain
2. Phantom pain and phantom sensations in upper limb amputees: An epidemiologic study
3. Rehabilitation and the long-term outcomes of persons with trauma-related amputations
4. Phantom limb pain
5. Chronic phantom sensations, phantom pain, residual limb pain, and other regional pain after lower limb amputation
6. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons
7. Immunolocalization of SNS/PN3 and NaN/SNS2 sodium channels in human pain states
8. The perception of phantom limbs
9. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: Implications for the treatment of postinjury pain hypersensitivity states
10. Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia
11. Randomized double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain
12. Systemic lidocaine silences ectopic neuroma and DRG discharges without blocking nerve conduction
13. The number needed to treat: A clinically useful measure of treatment effect
14. A systematic review of antidepressants in neuropathic pain
15. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
16. Phantom limb, phantom pain, and stump pain in amputees during the first 6 months following limb amputation
17. Phantom pain and sensation among British veteran populations
18. Phantom limb pain: Review of the literature on attributes and potential mechanisms
19. Systemic lidocaine for neuropathic pain relief
20. Neuropathic pain and injured nerve: Peripheral mechanisms
21. Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat
22. An in vitro study of ectopic discharge generation and adrenergic sensitivity in the intact, nerve-injured rat dorsal root ganglion
23. Effects of regional anesthesia on phantom limb pain are mirrored in changes in cortical reorganization
24. Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation
25. Extensive reorganization of the somatosensory cortex in adult humans after nervous system injury
26. A comparison of phantom sensations among amputees whose amputations were of civilian and military origins
27. Systemic and supraspinal but not spinal, opiates suppress allodynia in a rat neuropathic model
28. Immediate and long-term phantom limb pain in amputees: Incidence, clinical characteristics and relationship to preamputation limb pain
29. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions
30. Down-regulation of μ-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy
31. The reorganization of μ opioid receptors in the rat dorsal horn following peripheral axotomy
32. Are opioids effective in relieving neuropathic pain?
33. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain
34. The consumption of fentanyl is increased in rats with nociceptive but not neuropathic pain
35. The treatment of neuropathic pain: Antidepressants and opioids
36. Morphine responsiveness of chronic pain: Double blind randomized crossover study with patient controlled analgesia
37. Both intravenous lidocaine and morphine reduce pain of postherpetic neuralgia
38. Neuropathic pain can be relieved by drugs that are use dependent sodium channel blockers: Lidocaine, carbamazepine, mexiletine
39. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats
40. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury
41. A novel spinal action of mexiletine in spinal somatosensory transmission of nerve injured rats
42. Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action
43. The systemic administration of local anesthetics produces a selective depression of C-afferent fiber evoked activity in the spinal cord
44. Concentration-effect relationship for intravenous lidocaine infusions in human volunteers: Effects upon acute sensory thresholds and capsaicin-evoked hyperpathia
45. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: A prospective study